Korro Bio, Inc.
KRRO
$13.28
-$0.01-0.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -62.08% | -20.31% | 181.46% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -62.08% | -20.31% | 181.46% | -- | -- |
| Cost of Revenue | -31.94% | -18.63% | 6.70% | -28.72% | -13.45% |
| Gross Profit | 28.62% | 18.48% | 1.23% | 37.28% | 22.05% |
| SG&A Expenses | -13.28% | -9.31% | -12.38% | -12.95% | -5.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.67% | -14.89% | -1.78% | 5.09% | 13.08% |
| Operating Income | 22.25% | 14.61% | 6.31% | 2.61% | -6.22% |
| Income Before Tax | -15.94% | -29.19% | -39.77% | -0.62% | -7.04% |
| Income Tax Expenses | 783.16% | 490.32% | 351.77% | 173.68% | 102.13% |
| Earnings from Continuing Operations | -16.74% | -29.84% | -40.30% | -0.69% | -7.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.74% | -29.84% | -40.30% | -0.69% | -7.10% |
| EBIT | 22.25% | 14.61% | 6.31% | 2.61% | -6.22% |
| EBITDA | 21.19% | 14.57% | 7.38% | 4.42% | -5.08% |
| EPS Basic | -2.53% | -23.65% | -32.88% | 21.05% | 86.95% |
| Normalized Basic EPS | 34.93% | 17.25% | 8.13% | 22.22% | 87.14% |
| EPS Diluted | -2.53% | -23.65% | -32.88% | 21.05% | 86.95% |
| Normalized Diluted EPS | 34.93% | 17.25% | 8.13% | 22.22% | 87.14% |
| Average Basic Shares Outstanding | 28.25% | 7.44% | 5.34% | 18.80% | 65.87% |
| Average Diluted Shares Outstanding | 28.25% | 7.44% | 5.34% | 18.80% | 65.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |